A Comprehensive Introduction of the oneClick+ antigen platform

October 22, 2024 06:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Sanyou Bio provides oneClick+ antigen one-stop solution, from antigen analysis to personalized preparation, to help tumor immunotherapy research and development. oneClick+ antigen platform is designed to provide high-quality annotation-related protein sequences, including protein amino acid sequences, isoelectric points, subcellular localization, structural domains, modification sites, and other properties, and to demonstrate non-redundant datasets, which help scientists to simplify the antigen analysis process and solve antigen expression difficulties. Sanyou provides high quality protein expression products covering mammalian, insect and bacterial expression, three major high quality protein expression systems to help your protein expression research.

oneClick+ Antigen Access Address
Visit https://www.oneclick-plus.com/. Start accessing the oneClick+ platform and select "Design Antigen", to begin a one-stop shop for your antigen information. 

Platform Highlights

  1. Simplified input operation
    The oneClick+ platform for antigen analysis only requires you to enter the Uniprot ID corresponding to the protein. If you need to place a customized order, you can also select the desired expression system, protein amount, and other notes.

  2. Output Sequence Full Visualization
    The report outputs the amino acid sequences of the corresponding proteins, and proteins with > 2000 amino acids can also be displayed completely.

  3. Simplification of output information
    The output report demonstrates the physicochemical properties of the relevant antigen, including the number of amino acids, molecular weight, isoelectric point, subcellular localization, and protein type, in addition to the antigen's transmembrane structural domains, signal peptide and modification sites, and three-dimensional structural features, which filters out redundant information and reduces the time required to find information.

  4. Protein preparation difficulty evaluation function
    Sanyou Bio extracted the data of 56,547 proteins from Uniprot database, and analyzed the number of amino acids, cysteines and glycosylation sites at the amino acid level, and issued a protein preparation difficulty assessment, which is intended to be a reference for scientists to judge the difficulty of protein preparation. (You can click Protein preparation difficulty assessment to see the specific analysis process.)
    (Note: Due to the diversity of proteins and other multifaceted factors, the following is not a foregone conclusion and is for reference only.)

  5. Free reports to help research
    To obtain antigen information report outputs through the oneClick+ platform, you can enter your email, and we will send them to you in the form of a zip package. In addition, if you have any antigen customization needs or other questions, you can also leave your contact information and we will contact you within 24 hours.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.